Peng Liang
Président chez CLOVER BIOPHARMACEUTICALS, LTD.
Fortune : 9 M $ au 30/04/2024
Postes actifs de Peng Liang
Sociétés | Poste | Début | Fin |
---|---|---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Président | 31/10/2018 | - |
Clover Biopharmaceuticals Aus Pty Ltd. | Directeur/Membre du Conseil | 01/06/2017 | - |
Clover Biopharmaceuticals USA, Inc. | President | 01/04/2020 | - |
Treasurer | 01/04/2020 | - | |
Zhejiang Clover Biopharmaceutical, Inc. | Président | 01/08/2016 | - |
Clover Biopharmaceuticals Hong Kong Ltd. | Directeur/Membre du Conseil | 01/11/2018 | - |
Historique de carrière de Peng Liang
Anciens postes connus de Peng Liang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Vanderbilt University | Corporate Officer/Principal | 01/07/2008 | 01/06/2009 |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Fondateur | 01/06/2007 | - |
GenHunter Corp. | Fondateur | 01/10/1992 | - |
President | 01/10/1992 | - |
Formation de Peng Liang
Peking University | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Statistiques
Internationale
Chine | 6 |
Etats-Unis | 4 |
Australie | 2 |
Opérationnelle
Chairman | 2 |
Founder | 2 |
President | 2 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 6 |
---|---|
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Health Technology |
GenHunter Corp. | |
Clover Biopharmaceuticals USA, Inc. | |
Zhejiang Clover Biopharmaceutical, Inc. | |
Clover Biopharmaceuticals Aus Pty Ltd. | |
Clover Biopharmaceuticals Hong Kong Ltd. |
- Bourse
- Insiders
- Peng Liang
- Expérience